192328-47-5

Basic information

• Product Name: methyl (R)-N-(tert-butoxycarbonyl)-2-(3-bromo-4-methoxyphenyl)glycinate
• Synonyms: methyl (R)-N-(tert-butoxycarbonyl)-2-(3-bromo-4-methoxyphenyl)glycinate
• CAS NO: 192328-47-5
• Molecular Weight: 374.232
• Mol File: 192328-47-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl (R)-N-(tert-butoxycarbonyl)-2-(3-bromo-4-methoxyphenyl)glycinate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (R)-N-(tert-butoxycarbonyl)-2-(3-bromo-4-methoxyphenyl)glycinate(192328-47-5)
• EPA Substance Registry System: methyl (R)-N-(tert-butoxycarbonyl)-2-(3-bromo-4-methoxyphenyl)glycinate(192328-47-5)

Safety Data

• Hazardous Substances Data: 192328-47-5(Hazardous Substances Data)

Upstream product

• 139517-62-7 (2R)-2-(3-bromo-4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid 
• 74-88-4 methyl iodide 
• 162458-71-1 methyl (2R)-2-amino-2-(3-bromo-4-hydroxyphenyl)acetate 
• 139517-61-6 (R)-3-bromo-4-hydroxyphenylglycine 
• 77-78-1 dimethyl sulfate 
• 162458-72-2 methyl (2R)-2-(3-bromo-4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate 
• 22818-40-2 D-4-hydroxyphenylglycine 
• 174146-44-2 (R)-(3-Bromo-4-methoxy-phenyl)-tert-butoxycarbonylamino-acetic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 1197026-56-4 methyl (R)-N-(tert-butoxycarbonyl)-2-(3-[(R)-methyl-N-acetyl-1-tosyltryptophan-5-yl]-4-methoxyphenyl)glycinate 
• 1197026-57-5 methyl (R)-N-(tert-butoxycarbonyl)-2-(3-[(R)-methyl-N-acetyl-1-tosyltryptophan-6-yl]-4-methoxyphenyl)glycinate 

Relevant articles and documents

Synthesis of orthogonally protected actinoidic acid trimethyl ether

- We describe the asymmetric synthesis of actinoidic acid trimethyl ether with orthogonal protecting groups on the respective amino and carboxyl groups. The Stille biaryl coupling reaction of suitably functionalized aryl bromide and (trimethylstannyl)benz

Synthesis of the vancomycin CD and DE ring systems

Full details of the synthesis of the fully substituted vancomycin CD and DE ring systems are described and a potential solution to the control of the atropisomer stereochemistry is defined.